Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$70.1M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$64.4M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$41.9M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$40.7M |
| 5 |
Warner Bros
WBD
|
+$37.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$103M |
| 2 |
PLAN
Anaplan, Inc.
PLAN
|
+$89.2M |
| 3 |
ANAT
American National Group, Inc. Common Stock
ANAT
|
+$44M |
| 4 |
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
|
+$33.9M |
| 5 |
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Financials | 13.02% |
| 3 | Healthcare | 11.9% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Strategy Inc
MSTR
$48.7B
| $362K | 0.01% |
22,030
+11,350
| +106% | +$328K |
|
1452
Beyond Meat
BYND
$243M
| $361K | 0.01% |
+502
| New | +$481K |
|
|
X
1453
CALL
DELISTED
US Steel
X
| $361K | 0.01% |
20,200
+8,200
| +68% | +$224K |
|
1454
CALL
Emerson Electric
EMR
$87.9B
| $359K | 0.01% |
+4,500
| New | +$397K |
|
1455
TriNet
TNET
$3.19B
| $359K | 0.01% |
+4,626
| New | +$386K |
|
|
SWCH
1456
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $359K | 0.01% |
10,704
-21,781
| -67% | -$704K |
|
1457
Evolus
EOLS
$580M
| $358K | 0.01% |
+30,843
| New | +$364K |
|
1458
PUT
Generac Holdings
GNRC
$12B
| $358K | 0.01% |
+1,700
| New | +$418K |
|
1459
Hecla Mining
HL
$13.7B
| $358K | 0.01% |
91,388
-43,636
| -32% | -$227K |
|
1460
StoneX
SNEX
$8.17B
| $358K | 0.01% |
+23,222
| New | +$335K |
|
1461
Scotiabank
BNS
$106B
| $357K | 0.01% |
+6,029
| New | +$391K |
|
1462
First Bancorp
FBNC
$2.7B
| $357K | 0.01% |
+10,231
| New | +$382K |
|
1463
Phibro Animal Health
PAHC
$1.43B
| $357K | 0.01% |
18,668
-6,740
| -27% | -$128K |
|
|
SCHW
1464
Charles Schwab
SCHW
$197B
| $357K | 0.01% |
+5,644
| New | +$389K |
|
|
TRUE
1465
DELISTED
TrueCar
TRUE
| $356K | 0.01% |
137,473
-11,547
| -8% | -$38.3K |
|
1466
Zillow
ZG
$8.53B
| $356K | 0.01% |
11,183
+4,880
| +77% | +$193K |
|
1467
CALL
Fastenal
FAST
$58.8B
| $355K | 0.01% |
14,200
+400
| +3% | +$10.8K |
|
1468
CALL
Kulicke & Soffa
KLIC
$4.37B
| $355K | 0.01% |
+8,300
| New | +$411K |
|
1469
CoreCivic
CXW
$3.35B
| $354K | 0.01% |
+31,832
| New | +$384K |
|
1470
CALL
General Dynamics
GD
$104B
| $354K | 0.01% |
1,600
-4,800
| -75% | -$1.1M |
|
1471
ImmunityBio
IBRX
$8.03B
| $354K | 0.01% |
+95,140
| New | +$382K |
|
1472
Biogen
BIIB
$32.2B
| $353K | 0.01% |
1,733
-3,259
| -65% | -$666K |
|
|
CMCT
1473
Creative Media & Community Trust
CMCT
$14.3M
| $353K | 0.01% |
2
| – | – |
|
1474
PUT
Roku
ROKU
$23.5B
| $353K | 0.01% |
+4,300
| New | +$417K |
|
|
FRC
1475
DELISTED
First Republic Bank
FRC
| $353K | 0.01% |
2,448
-31,932
| -93% | -$4.79M |
|
Similar funds
Paul Tudor Jones's Q2 2022 Portfolio in Review
As of Q2 2022, Paul Tudor Jones held 2,681 positions worth $3.81B, down 11% from $4.27B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Paul Tudor Jones deployed $332M of net new capital in Q2 2022, opening 766 new positions and adding to 644 existing holdings. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Liberty Broadband Class C, an estimated $18.4M trimmed.
- Paul Tudor Jones's largest Q2 2022 buy was Biohaven Pharmaceutical Holding Company Ltd.: 327,735 shares worth $47.8M.
- Paul Tudor Jones added most to Alleghany Corp in Q2 2022, an estimated $70.1M increase.
- Paul Tudor Jones's biggest Q2 2022 reduction was Liberty Broadband Class C, cutting an estimated $18.4M.
- Paul Tudor Jones fully exited Cerner Corp in Q2 2022, selling an estimated $103M.
- Paul Tudor Jones's ten largest holdings make up 10% of its $3.81B portfolio in Q2 2022.
- Paul Tudor Jones opened 766 new positions and closed 638 in Q2 2022.
- Paul Tudor Jones's portfolio value fell 11% quarter-over-quarter to $3.81B.
Based on Tudor Investment Corp's 13F filing for Q2 2022, filed 15 Aug 2022.